Arylstibonates structurally resemble phosphotyrosine side chains in proteins and here we addressed the ability of such compounds to act as inhibitors of a panel of mammalian tyrosine and dual-specificity phosphatases. Two arylstibonates both possessing a carboxylate side chain were identified as potent inhibitors of the protein tyrosine phosphatase PTP-ß. In addition, they inhibited the dual-specificity, cell cycle regulatory phosphatases Cdc25a and Cdc25b with sub-micromolar potency. However, the Cdc25c phosphatase was not affected demonstrating that arylstibonates may be viable leads from which to develop isoform specific Cdc25 inhibitors.
Arylstibonates structurally resemble n class="Chemical">phosphotyrosine side chains in proteins and here we addressed the ability of such compounds to act as inhibitors of a panel of mammaliantyrosine and dual-specificity phosphatases. Two arylstibonates both possessing a carboxylate side chain were identified as potent inhibitors of the protein tyrosine phosphatase PTP-ß. In addition, they inhibited the dual-specificity, cell cycle regulatory phosphatases Cdc25a and Cdc25b with sub-micromolar potency. However, the Cdc25c phosphatase was not affected demonstrating that arylstibonates may be viable leads from which to develop isoform specific Cdc25 inhibitors.
Authors: J C Whisstock; S Romero; R Gurung; H Nandurkar; L M Ooms; S P Bottomley; C A Mitchell Journal: J Biol Chem Date: 2000-11-24 Impact factor: 5.157
Authors: David J Pagliarini; Sandra E Wiley; Michelle E Kimple; Jesse R Dixon; Patrick Kelly; Carolyn A Worby; Patrick J Casey; Jack E Dixon Journal: Mol Cell Date: 2005-07-22 Impact factor: 17.970
Authors: Kristen M Picha; Smita S Patel; Sreekala Mandiyan; James Koehn; Lawrence P Wennogle Journal: J Biol Chem Date: 2006-11-29 Impact factor: 5.157
Authors: G Huyer; S Liu; J Kelly; J Moffat; P Payette; B Kennedy; G Tsaprailis; M J Gresser; C Ramachandran Journal: J Biol Chem Date: 1997-01-10 Impact factor: 5.157